Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05652686
Title A Study of PT217 in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Phanes Therapeutics
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Sarah Cannon Research Institute at HealthONE RECRUITING Denver Colorado 80218 United States Details
Massachusetts General Hospital RECRUITING Boston Massachusetts 02114 United States Details
Dana-Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
University of North Carolina at Chapel Hill RECRUITING Chapel Hill North Carolina 27599 United States Details
Sarah Cannon Research Institute University of Oklahoma RECRUITING Oklahoma City Oklahoma 73104 United States Details
Mays Cancer Center / University of Texas, San Antonio RECRUITING San Antonio Texas 78229 United States Details
NEXT Virginia RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from for the field